4'-(trans-4-Pentylcyclohexyl)-[1,1'-biphenyl]-4-carbonitrile, 98%, 100g

(4-((4-Fluorobenzyl)oxy)phenyl)boronic acid, 95.0%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(1H-pyrrolo[2,3-b]pyridin-3-yl)propanoic acid, 95.0%, 5g

GC-Kapillarsäule ROTI®Cap-5, unpolar, L 30 m, Ø-Innen 0,32 mm, Filmd. 5,00 µm, 1 Stück

3-(4-Chloro-3-fluorophenyl)propan-1-amine, 95%, 1g

1-Acetyl-1,2,3,4-tetrahydroquinoline>98.0%(GC)25g

(4-Bromothiophen-2-yl)methanamine hydrochloride, 95.0%, 250mg

4-(1H-Imidazo[4,5-f][1,10]phenanthrolin-2-yl)benzoic acid, 98%, 250mg

8-Fluoroquinoline>97.0%(GC)1g

6-(3-Methoxyphenoxy)pyridine-3-boronic acid, 97%, 1g

(11bS)-4-Hydroxy-2,6-bis(2,3,4,5,6-pentafluorophenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 99.93%, 1g

1-(Diphenylmethyl)-3-(methoxy)azetidine, 98.0%, 1g

2-Bromo-4-methyl-6-nitroaniline, 97.0%, 100g